We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
COMPASS: deCOMPressing stomA and two-Stage elective resection vs. emergency reSection in patients with left-sided obstructive colon cancer.
- Authors
Mathieu, Pecqueux; Marius, Distler; Radulova-Mauersberger, Olga; Neckmann, Ulrike; Korn, Sandra; Praetorius, Christian; Fritzmann, Johannes; Klimova, Anna; Jürgen, Weitz; Christoph, Kahlert
- Abstract
Background: Colorectal cancer stands as a prevalent cause of cancer-related mortality, necessitating effective treatment strategies. Acute colonic obstruction occurs in approximately 20% of patients and represents a surgical emergency with substantial morbidity and mortality. The optimal approach for managing left-sided colon cancer with acute colonic obstruction remains debatable, with no consensus on whether emergency resection or bridge-to-surgery, involving initial decompressing stoma and subsequent elective resection after recovery, should be employed. Current studies show a decrease in morbidity and short-term mortality for the bridge-to-surgery approach, yet it remains unclear if the long-term oncological outcome is equivalent to emergency resection. Methods: This prospective, randomized, multicenter trial aims to investigate the management of obstructive left-sided colon cancer in a comprehensive manner. The study will be conducted across 26 university hospitals and 40 academic hospitals in Germany. A total of 468 patients will be enrolled, providing a cohort of 420 evaluable patients, with an equal distribution of 210 patients in each treatment arm. Patients with left-sided colon cancer, defined as cancer between the left splenic flexure and > 12 cm ab ano and obstruction confirmed by X-ray or CT scan, are eligible. Randomization will be performed in a 1:1 ratio, assigning patients either to the oncological emergency resection group or the bridge-to-surgery group, wherein patients will undergo diverting stoma and subsequent elective oncological resection after recovery. The primary endpoint of this trial will be 120-day mortality, allowing for consideration of the time interval between diverting stoma and resection. Discussion: The findings derived from this trial possess the potential to reshape the current clinical approach of emergency resection for obstructive left-sided colon cancer by favoring the bridge-to-surgery practice, provided that a reduction in morbidity can be achieved without compromising the oncological long-term outcome. Trial registration: German Clinical Trials Register (DRKS) under the identifier DRKS00031827. Registered on May 15, 2023. Protocol: 28.04.2023, protocol version 2.0F.
- Subjects
GERMANY; COLON cancer; SURGICAL stomas; COLORECTAL cancer; SURGICAL emergencies; CANCER-related mortality; TRANSCRANIAL magnetic stimulation
- Publication
Trials, 2023, Vol 24, Issue 1, p1
- ISSN
1745-6215
- Publication type
Article
- DOI
10.1186/s13063-023-07636-y